SOURCE: IBC Life Sciences

June 18, 2008 14:52 ET

IBC Announces D2D: IBC's Discovery2Diagnostics Conference & Exhibition

Synergizing New Technologies, Novel Research, Key Clinical Data, and Bold Development Strategies for Clinical Success

WESTBOROUGH, MA--(Marketwire - June 18, 2008) - IBC's Discovery2Diagnostics Conference & Exhibition will be held October 20-22, 2008 at the Manchester Grand Hyatt, in San Diego, CA. Developed through content from the 15th Annual Chips to Hits®, 7th Annual Biomarkers, and 7th annual Molecular Diagnostics, D2D brings together discovery technology, biomarkers, molecular diagnostics and molecular theranostics.

The conference agenda includes eight keynote presentations from:

--  Isidore Rigoutsos, Ph.D., IBM Thomas J Watson Research Center
--  Scott Patterson, Ph.D., Amgen Inc.
--  Richard Naples, BD, Medical - Pharmaceutical Systems
--  Mahendra Rao, MD, Ph.D., Invitrogen Corporation
--  Dietrich Stephan, Ph.D., Translational Genomics Research Institute
--  Bernhard Palsson, Ph.D., University of California at San Diego
--  David Persing, MD, Ph.D., Cepheid
--  Thomas Cebula, Ph.D., CFSAN, FDA
    

D2D includes three conference tracks: Sequencing and Detection Technologies, Molecular Diagnostics and Biomarkers. Sessions will address RNAi related research and development as it affects sequencing and detection technologies, biomarkers and molecular diagnostics, and recent work to deliver point-of-care (or near POC) molecular diagnostics. Sessions with panel discussions on related regulatory and reimbursement issues will also be featured.

In addition, D2D will have an exhibit hall with 50 companies and 80 poster presentations.

For up-to-date information and to register for this event, visit www.Discovery2Diagnostics.com.

About IBC Life Sciences

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit: http://www.IBCLifeSciences.com.

Contact Information

  • Contact:
    Steve Garofalo
    IBC Life Sciences
    508-614-1235
    Email Contact